Breast cancer survivors must remain vigilant for recurrence signs, which can manifest locally, regionally, or distantly. New ...

Accord BioPharma, Inc., the specialty division of Intas Pharmaceuticals, Ltd., focused on development of oncology, immunology, and critical care therapies, announced today the U.S. Food and Drug ...

While traditional induction therapy for newly diagnosed stage 2 myeloma often focuses on combinations of proteasome inhibitors, immunomodulatory drugs, and steroids, these newer immunotherapy classes ...

Breast cancer is the most common cancer in women, so it's vital to know the signs and symptoms to look out for - and how to ...